Reprint

Nanomedicine Based Drug Delivery Systems: Recent Developments and Future Prospects

Edited by
May 2023
242 pages
  • ISBN978-3-0365-7761-6 (Hardback)
  • ISBN978-3-0365-7760-9 (PDF)

This book is a reprint of the Special Issue Nanomedicine Based Drug Delivery Systems: Recent Developments and Future Prospects that was published in

Chemistry & Materials Science
Medicine & Pharmacology
Summary

This reprint entitled "Nanomedicine Based Drug Delivery Systems: Recent Developments and Future Prospects" contains 14 articles in total. This includes one editorial, ten research articles, and three review articles. All articles are associated with nanomedicine-based drug delivery systems for the solubility, bioavailability, and therapeutic enhancement of active drug molecules. In recent years, there has been a tremendous amount of research on nanomedicine-based drug delivery systems. This reprint has brought together prominent scientists who have explored a diverse range of applications of nanomedicine-based drug delivery systems. I believe that further clinical and toxicological studies on both animal and human models are still required to explore the complete potential and commercial exploitation of nanomedicine-based drug delivery systems. The diverse and critical perspectives within this reprint provide sufficient information on the development, characterization, and evaluation of nanomedicine-based drug delivery systems.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
bioflavonoid; droplet size; hepatoprotective effects; luteolin; SNEDDS; cancer; smart nanocarriers; drug targeting; nanoparticles; stimulus for drug release; bioavailability; ciprofloxacin; lipid-based colloidal carriers; ocular delivery; turmeric rhizome extract; turmeric oil; curcumin; HepG2; nanoparticles; anticancer; quality by design; quality planning; initial risk assessment; critical factors; thermosensitive liposomes; thin-film hydration method; dental diseases; essential oils; herb; natural products; nanotechnology; regulations; tedizolid-phosphate; chitosan; nanoparticles; antibacterial; eye-irritation transcorneal-permeation; drug delivery; nanotechnology; contraception; levonorgestrel; liposomes; microneedle; sustained-release; apremilast; psoriatic arthritis; pharmacokinetics studies; SNEDDS; solubility; dissolution; oral bioavailability; functionalized fullerenes; fullerenols; antibiotics; gentamicin; antibacterial properties; cytotoxicity; skin fibroblasts; nanomedicine; tedizolid; antimicrobial; nanocrystals; eyeirritation; ocular pharmacokinetics; transcorneal permeation; drug delivery; nanomedicine; liposomes; quality by Design (QbD); nano-pharmaceuticals; pharmaceutical industry; polyamidoamine dendrimers; erlotinib; non-small-cell lung cancer; cytotoxicity; n/a